Cargando…

Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study

BACKGROUND: Since 2014, England has seen increased scarlet fever activity unprecedented in modern times. In 2016, England's scarlet fever seasonal rise coincided with an unexpected elevation in invasive Streptococcus pyogenes infections. We describe the molecular epidemiological investigation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynskey, Nicola N, Jauneikaite, Elita, Li, Ho Kwong, Zhi, Xiangyun, Turner, Claire E, Mosavie, Mia, Pearson, Max, Asai, Masanori, Lobkowicz, Ludmila, Chow, J Yimmy, Parkhill, Julian, Lamagni, Theresa, Chalker, Victoria J, Sriskandan, Shiranee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838661/
https://www.ncbi.nlm.nih.gov/pubmed/31519541
http://dx.doi.org/10.1016/S1473-3099(19)30446-3
_version_ 1783467262595825664
author Lynskey, Nicola N
Jauneikaite, Elita
Li, Ho Kwong
Zhi, Xiangyun
Turner, Claire E
Mosavie, Mia
Pearson, Max
Asai, Masanori
Lobkowicz, Ludmila
Chow, J Yimmy
Parkhill, Julian
Lamagni, Theresa
Chalker, Victoria J
Sriskandan, Shiranee
author_facet Lynskey, Nicola N
Jauneikaite, Elita
Li, Ho Kwong
Zhi, Xiangyun
Turner, Claire E
Mosavie, Mia
Pearson, Max
Asai, Masanori
Lobkowicz, Ludmila
Chow, J Yimmy
Parkhill, Julian
Lamagni, Theresa
Chalker, Victoria J
Sriskandan, Shiranee
author_sort Lynskey, Nicola N
collection PubMed
description BACKGROUND: Since 2014, England has seen increased scarlet fever activity unprecedented in modern times. In 2016, England's scarlet fever seasonal rise coincided with an unexpected elevation in invasive Streptococcus pyogenes infections. We describe the molecular epidemiological investigation of these events. METHODS: We analysed changes in S pyogenes emm genotypes, and notifications of scarlet fever and invasive disease in 2014–16 using regional (northwest London) and national (England and Wales) data. Genomes of 135 non-invasive and 552 invasive emm1 isolates from 2009–16 were analysed and compared with 2800 global emm1 sequences. Transcript and protein expression of streptococcal pyrogenic exotoxin A (SpeA; also known as scarlet fever or erythrogenic toxin A) in sequenced, non-invasive emm1 isolates was quantified by real-time PCR and western blot analyses. FINDINGS: Coincident with national increases in scarlet fever and invasive disease notifications, emm1 S pyogenes upper respiratory tract isolates increased significantly in northwest London in the March to May period, from five (5%) of 96 isolates in 2014, to 28 (19%) of 147 isolates in 2015 (p=0·0021 vs 2014 values), to 47 (33%) of 144 in 2016 (p=0·0080 vs 2015 values). Similarly, invasive emm1 isolates collected nationally in the same period increased from 183 (31%) of 587 in 2015 to 267 (42%) of 637 in 2016 (p<0·0001). Sequences of emm1 isolates from 2009–16 showed emergence of a new emm1 lineage (designated M1(UK))—with overlap of pharyngitis, scarlet fever, and invasive M1(UK) strains—which could be genotypically distinguished from pandemic emm1 isolates (M1(global)) by 27 single-nucleotide polymorphisms. Median SpeA protein concentration in supernatant was nine-times higher among M1(UK) isolates (190·2 ng/mL [IQR 168·9–200·4]; n=10) than M1(global) isolates (20·9 ng/mL [0·0–27·3]; n=10; p<0·0001). M1(UK) expanded nationally to represent 252 (84%) of all 299 emm1 genomes in 2016. Phylogenetic analysis of published datasets identified single M1(UK) isolates in Denmark and the USA. INTERPRETATION: A dominant new emm1 S pyogenes lineage characterised by increased SpeA production has emerged during increased S pyogenes activity in England. The expanded reservoir of M1(UK) and recognised invasive potential of emm1 S pyogenes provide plausible explanation for the increased incidence of invasive disease, and rationale for global surveillance. FUNDING: UK Medical Research Council, UK National Institute for Health Research, Wellcome Trust, Rosetrees Trust, Stoneygate Trust.
format Online
Article
Text
id pubmed-6838661
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Science ;, The Lancet Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-68386612019-11-12 Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study Lynskey, Nicola N Jauneikaite, Elita Li, Ho Kwong Zhi, Xiangyun Turner, Claire E Mosavie, Mia Pearson, Max Asai, Masanori Lobkowicz, Ludmila Chow, J Yimmy Parkhill, Julian Lamagni, Theresa Chalker, Victoria J Sriskandan, Shiranee Lancet Infect Dis Article BACKGROUND: Since 2014, England has seen increased scarlet fever activity unprecedented in modern times. In 2016, England's scarlet fever seasonal rise coincided with an unexpected elevation in invasive Streptococcus pyogenes infections. We describe the molecular epidemiological investigation of these events. METHODS: We analysed changes in S pyogenes emm genotypes, and notifications of scarlet fever and invasive disease in 2014–16 using regional (northwest London) and national (England and Wales) data. Genomes of 135 non-invasive and 552 invasive emm1 isolates from 2009–16 were analysed and compared with 2800 global emm1 sequences. Transcript and protein expression of streptococcal pyrogenic exotoxin A (SpeA; also known as scarlet fever or erythrogenic toxin A) in sequenced, non-invasive emm1 isolates was quantified by real-time PCR and western blot analyses. FINDINGS: Coincident with national increases in scarlet fever and invasive disease notifications, emm1 S pyogenes upper respiratory tract isolates increased significantly in northwest London in the March to May period, from five (5%) of 96 isolates in 2014, to 28 (19%) of 147 isolates in 2015 (p=0·0021 vs 2014 values), to 47 (33%) of 144 in 2016 (p=0·0080 vs 2015 values). Similarly, invasive emm1 isolates collected nationally in the same period increased from 183 (31%) of 587 in 2015 to 267 (42%) of 637 in 2016 (p<0·0001). Sequences of emm1 isolates from 2009–16 showed emergence of a new emm1 lineage (designated M1(UK))—with overlap of pharyngitis, scarlet fever, and invasive M1(UK) strains—which could be genotypically distinguished from pandemic emm1 isolates (M1(global)) by 27 single-nucleotide polymorphisms. Median SpeA protein concentration in supernatant was nine-times higher among M1(UK) isolates (190·2 ng/mL [IQR 168·9–200·4]; n=10) than M1(global) isolates (20·9 ng/mL [0·0–27·3]; n=10; p<0·0001). M1(UK) expanded nationally to represent 252 (84%) of all 299 emm1 genomes in 2016. Phylogenetic analysis of published datasets identified single M1(UK) isolates in Denmark and the USA. INTERPRETATION: A dominant new emm1 S pyogenes lineage characterised by increased SpeA production has emerged during increased S pyogenes activity in England. The expanded reservoir of M1(UK) and recognised invasive potential of emm1 S pyogenes provide plausible explanation for the increased incidence of invasive disease, and rationale for global surveillance. FUNDING: UK Medical Research Council, UK National Institute for Health Research, Wellcome Trust, Rosetrees Trust, Stoneygate Trust. Elsevier Science ;, The Lancet Pub. Group 2019-11 /pmc/articles/PMC6838661/ /pubmed/31519541 http://dx.doi.org/10.1016/S1473-3099(19)30446-3 Text en © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lynskey, Nicola N
Jauneikaite, Elita
Li, Ho Kwong
Zhi, Xiangyun
Turner, Claire E
Mosavie, Mia
Pearson, Max
Asai, Masanori
Lobkowicz, Ludmila
Chow, J Yimmy
Parkhill, Julian
Lamagni, Theresa
Chalker, Victoria J
Sriskandan, Shiranee
Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
title Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
title_full Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
title_fullStr Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
title_full_unstemmed Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
title_short Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study
title_sort emergence of dominant toxigenic m1t1 streptococcus pyogenes clone during increased scarlet fever activity in england: a population-based molecular epidemiological study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838661/
https://www.ncbi.nlm.nih.gov/pubmed/31519541
http://dx.doi.org/10.1016/S1473-3099(19)30446-3
work_keys_str_mv AT lynskeynicolan emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT jauneikaiteelita emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT lihokwong emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT zhixiangyun emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT turnerclairee emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT mosaviemia emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT pearsonmax emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT asaimasanori emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT lobkowiczludmila emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT chowjyimmy emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT parkhilljulian emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT lamagnitheresa emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT chalkervictoriaj emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy
AT sriskandanshiranee emergenceofdominanttoxigenicm1t1streptococcuspyogenescloneduringincreasedscarletfeveractivityinenglandapopulationbasedmolecularepidemiologicalstudy